BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20092931)

  • 1. COPD evaluation: back to the future.
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Feb; 46(2):53-5. PubMed ID: 20092931
    [No Abstract]   [Full Text] [Related]  

  • 2. Nosology for our day: its application to chronic obstructive pulmonary disease.
    Snider GL
    Am J Respir Crit Care Med; 2003 Mar; 167(5):678-83. PubMed ID: 12598211
    [No Abstract]   [Full Text] [Related]  

  • 3. The Concavity of the Maximal Expiratory Flow-Volume Curve Reflects the Extent of Emphysema in Obstructive Lung Diseases.
    Mochizuki F; Iijima H; Watanabe A; Tanabe N; Sato S; Shiigai M; Fujiwara K; Shimada T; Ishikawa H; Kanazawa J; Yatagai Y; Masuko H; Sakamoto T; Muro S; Hizawa N
    Sci Rep; 2019 Sep; 9(1):13159. PubMed ID: 31511572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
    Löfdahl JM; Cederlund K; Nathell L; Eklund A; Sköld CM
    Eur Respir J; 2005 Feb; 25(2):275-81. PubMed ID: 15684291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HRCT-defined emphysema is not COPD to be treated with inhalers.
    Enright P
    Thorax; 2014 May; 69(5):401-2. PubMed ID: 24393768
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical significance of CT evaluation in chronic obstructive pulmonary disease].
    Cheng T; Cheng Q; Wan H
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):45-7. PubMed ID: 24694974
    [No Abstract]   [Full Text] [Related]  

  • 7. The extent of emphysema in patients with COPD.
    Shaker SB; Stavngaard T; Hestad M; Bach KS; Tonnesen P; Dirksen A
    Clin Respir J; 2009 Jan; 3(1):15-21. PubMed ID: 20298367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution computed tomography features in patients with chronic obstructive pulmonary disease.
    Gupta PP; Yadav R; Verma M; Gupta KB; Agarwal D
    Singapore Med J; 2009 Feb; 50(2):193-200. PubMed ID: 19296036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotype specific therapy of COPD].
    Rothe T
    Praxis (Bern 1994); 2014 Dec; 103(25):1509-14. PubMed ID: 25491053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD.
    Gietema HA; Edwards LD; Coxson HO; Bakke PS;
    Respir Med; 2013 Aug; 107(8):1201-9. PubMed ID: 23711580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique spirometric phenotype in COPD.
    Bon JM; Weissfeld JL; Sciurba FC
    Am J Respir Crit Care Med; 2008 Aug; 178(4):431-2. PubMed ID: 18676963
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe centrilobular emphysema in a patient without airflow obstruction.
    Reid J; Cockcroft D
    Chest; 2002 Jan; 121(1):307-8. PubMed ID: 11796478
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic obstructive pulmonary disease].
    Lange P
    Ugeskr Laeger; 2013 Apr; 175(16):1105-8. PubMed ID: 23651748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirometry in chronic obstructive lung disease (COPD).
    Karkhanis VS; Joshi JM
    J Assoc Physicians India; 2012 Feb; 60 Suppl():22-6. PubMed ID: 23155809
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema.
    Omori H; Tsuji M; Sata K; Iyonaga C; Narimatsu A; Mihara S; Marubayashi T; Tomiguchi S; Nomori H; Kohrogi H; Katoh T
    Respirology; 2009 May; 14(4):551-8. PubMed ID: 19386068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic obstructive pulmonary disease phenotypes and the related characteristics of treatment response].
    Pan MM; Sun TY; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):293-6. PubMed ID: 23945345
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography.
    Tsushima K; Sone S; Fujimoto K; Kubo K; Morita S; Takegami M; Fukuhara S
    COPD; 2010 Apr; 7(2):117-25. PubMed ID: 20397812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The path to personalised medicine in COPD.
    Agusti A
    Thorax; 2014 Sep; 69(9):857-64. PubMed ID: 24781218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Computed tomography and study of external respiratory function in the diagnosis of complications due to chronic obstructive lung disease].
    Shoĭkhet IaN; Bednarzhevskaia TV
    Klin Med (Mosk); 2004; 82(7):65-8. PubMed ID: 15449780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.